Aileron Therapeutics, Inc. (ALRN)

NASDAQ: ALRN · IEX Real-Time Price · USD
0.400
-0.010 (-2.44%)
At close: May 26, 2022 4:00 PM
0.395
-0.005 (-1.250%)
After-hours:May 26, 2022 7:33 PM EDT

Cash Flow Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year2021202020192018201720162015
Net Income
-26.16-21.16-29.37-31.55-22.6-18.12-12.88
Depreciation & Amortization
0.120.160.160.220.130.230.33
Share-Based Compensation
2.261.892.123.281.750.690.63
Other Operating Activities
0.03-1.380.620.120.22.190.22
Operating Cash Flow
-23.75-20.48-26.47-27.93-20.53-15.01-11.71
Capital Expenditures
-0.090.2-0.15-4.42-0.140-0.09
Change in Investments
-35.836.21-2.6629.11-38.77010.01
Other Investing Activities
00000-0.030.71
Investing Cash Flow
-35.926.41-2.8124.69-38.91-0.0310.63
Share Issuance / Repurchase
55.6615.4123.960.0450.12-0.16-1.27
Debt Issued / Paid
00.3902.47000
Other Financing Activities
00000.4732.14-0.09
Financing Cash Flow
55.6615.823.962.5250.5931.99-1.36
Net Cash Flow
-4.011.74-5.32-0.72-8.8516.95-2.44
Free Cash Flow
-23.85-20.27-26.63-32.35-20.67-15.01-11.8
Free Cash Flow Per Share
-0.27-0.58-1.08-2.19-2.78-34.94-29.46
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).